Locoregional treatments before liver transplantation for hepatocellular carcinoma: A study from the European Liver Transplant Registry

ConclusionAdjusting for factors related to prognosis, disease severity and tumor aggressiveness, RFA was highly beneficial for overall and HCC‐specific survival. The effect may represent a selection of patients with favorable tumor biology; however, the treatment may be effective per se by halting tumor progression. Clinicaltrials. gov number: NCT02995096.This article is protected by copyright. All rights reserved.

Source: Transplant International - January 30, 2018 Category: Transplant Surgery Authors: Hans ‐Christian Pommergaard, Andreas Arendtsen Rostved, René Adam, Lau Caspar Thygesen, Mauro Salizzoni, Miguel Angel Gómez Bravo, Daniel Cherqui, Paolo De Simone, Karim Boudjema, Vincenzo Mazzaferro, Olivier Soubrane, Juan Carlos García‐Valdecasas Tags: Original Article Source Type: research